Adial Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award
Adial Pharmaceuticals, Inc. (ADIL) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award of 1.54 million shares for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward · last filed 2023-05-12
- Adial Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2023-03-31 was 1.54M shares.
- Adial Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2022-12-31 was 0.00 shares.
- Adial Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2021-03-31 was 918.00K shares, a 16.55% decline year-over-year.
- Adial Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2020-12-31 was -30.00K shares.
- Adial Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for fiscal 2022 was 731.67K shares.
- Adial Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for fiscal 2020 was 1.23M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 12 month |
|---|---|---|---|---|---|---|
| 2023-03-31 | 1.54M shares 10-Q · filed 2023-05-12 | 1.54M shares derived: sum of 2 quarters · filed 2023-05-12 | ||||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 731.67K shares 10-K · filed 2023-03-30 | ||||
| 2022-09-30 | 731.67K shares 10-Q · filed 2022-11-14 | |||||
| 2021-03-31 | 918.00K shares 10-Q · filed 2021-05-17 | 888.00K shares derived: sum of 2 quarters · filed 2021-05-17 | 888.00K shares derived: sum of 3 quarters · filed 2021-05-17 | 1.04M shares derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2021-02-08 | 10.00K shares 10-K · filed 2023-03-30 | 10.00K shares 10-K · filed 2022-03-28 | ||||
| 2020-12-31 | -30.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -30.00K shares derived: sum of 2 quarters · filed 2021-03-22 | 125.00K shares derived: sum of 3 quarters · filed 2021-03-22 | 1.23M shares 10-K · filed 2021-03-22 | ||
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | 155.00K shares derived: sum of 2 quarters · filed 2020-11-13 | 1.25M shares 10-Q · filed 2020-11-13 | |||
| 2020-06-30 | 155.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 1.25M shares 10-Q · filed 2020-08-13 | ||||
| 2020-03-31 | 1.10M shares 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |